Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $523,841 - $625,141
-3,468 Reduced 57.52%
2,561 $396,000
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $148,665 - $166,845
-928 Reduced 13.34%
6,029 $1.07 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $358,959 - $399,432
-2,225 Reduced 24.23%
6,957 $1.14 Million
Q2 2022

Aug 15, 2022

BUY
$168.19 - $186.01 $1.54 Million - $1.71 Million
9,182 New
9,182 $1.63 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Connacht Asset Management LP Portfolio

Follow Connacht Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connacht Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Connacht Asset Management LP with notifications on news.